AJP - GI Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol (May 31, 2007). doi:10.1152/ajpgi.00128.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/G374    most recent
00128.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amin, Md. R.
Right arrow Articles by Malakooti, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amin, Md. R.
Right arrow Articles by Malakooti, J.
Submitted on March 14, 2007
Accepted on May 28, 2007

Involvement of Sp1 and Sp3 in differential regulation of the human NHE3 promoter activity by sodium butyrate and IFN-{gamma}/TNF-{alpha}

Md. Ruhul Amin1, Pradeep K. Dudeja2, Krishnamurthy Ramaswamy2, and Jaleh Malakooti2*

1 Medicine, University of Illinois at Chicago, Chicago, Illinois, United States
2 Medicine, University of Illinois at Chicago, Chicago, United States; Jesse Brown VA Medical Center, Chicago, United States

* To whom correspondence should be addressed. E-mail: malakoot{at}uic.edu.

Previously, we reported that IFN-{gamma}/TNF-{alpha}down-regulate the expression of the human NHE3 gene by modulating Sp1/Sp3 transcription factors in C2BBe1 cells. It is reported that butyrate inhibits IFN-{gamma} and TNF-{alpha} signaling pathways. In this study, we have investigated the effect of sodium butyrate (NaB) and IFN-{gamma}/TNF-{alpha} on the human NHE3 promoter activity. In transient transfection studies, NaB (5 mM) led to 10-fold stimulation of NHE3 promoter activity after incubation for 24 hours. Using 5'-deletion analysis, the NaB-responsive region was mapped to the NHE3 core promoter, bp -95 to + 5, which we had shown previously to confer responsiveness to IFN-{gamma}/TNF-{alpha}. The stimulatory effect of NaB on the NHE3 promoter was reduced by 60% in the presence of IFN-{gamma}/TNF-{alpha}. Mutually, the repressive effect of these cytokines was attenuated by NaB. Knockdown of Sp1 and Sp3 expression using siRNA resulted in a significant resistance to NaB effects. NaB treatment showed no effect on Sp1 and Sp3 protein expression as assessed by Western blot analyses. Gel mobility shift assays with nuclear proteins from NaB-treated cells showed enhanced binding of Sp1 and Sp3 to the NHE3 promoter. Phosphatase inhibitor, okadaic acid (200 nM), blocked the stimulatory effect of NaB on the NHE3 promoter. NaB effects on the NHE3 promoter were significantly attenuated by PP1{alpha}- and PP2A{alpha}-specific siRNA transfection. Our data suggest that the differential regulation of the NHE3 gene expression by NaB and IFN-{gamma}/TNF-{alpha} is mediated through alternative pathways that converge on Sp1/Sp3.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.